Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid
NCT ID: NCT03272958
Last Updated: 2019-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
63 participants
OBSERVATIONAL
2017-11-07
2018-10-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of this study is to learn more about pruritus characteristics of patients with bullous pemphigoid, and in consequence to better understand the pathophysiology of pruritus, and then to better treat pruritus in this condition.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence of Sleep Disturbances in Bullous Pemphigoid Patients.
NCT07188402
A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine
NCT06087627
Identification of Vulnerability Factors in the Course of Pemphigus Patients
NCT02237313
Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis
NCT07276425
Retrospective Study of the Effects of Sub-pathologic Phenotypes of BP on Clinical Management and Prognosis
NCT06213909
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pruriginous bullous pemphigoid lately diagnosed.
* Without PB treatment
* MMS (Mini Mental State Examination) ≥ 21
* In hospitalization or consultation
Exclusion Criteria
* nursing women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CH Argenteuil
Argenteuil, , France
AP-HP, Hôpital Avicenne
Bobigny, , France
CHU de Bordeaux
Bordeaux, , France
CHRU de Brest
Brest, , France
CHU Caen
Caen, , France
CHU de Clermont-Ferrand
Clermont-Ferrand, , France
AP-HP, Hôpital Henri Mondor
Créteil, , France
CHU Le Havre
Le Havre, , France
HP-HM
Marseille, , France
CHU de Montpellier
Montpellier, , France
CH de Niort
Niort, , France
AP-HP, Hôpital Cochin
Paris, , France
AP-HP, Hôpital Bichat
Paris, , France
CHU de Reims
Reims, , France
CHU de Rouen
Rouen, , France
CHU de Saint-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
29BRC17.0066 ( PRURIPB)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.